The Entourage Effect CEO Lisa Varley has been shortlisted for a prominent award that honours outstanding business leaders across Australia.
Varley is one of 10 finalists nominated for CEO Magazine's CEO of the Year award in the healthcare category.
All finalists were recognised for their "inspiring efforts" in advancing healthcare throughout Australia.
Varley, who stepped into the CEO role at The Entourage Effect in January, called the shortlisting an "honour," while crediting her team and the broader medicinal cannabis sector for the recognition.
"Such a prestigious nomination is a reflection of the incredible team we've built at The Entourage Effect, where none of this would be possible without their hard work and dedication," she said.
"And beyond our team, this recognition serves as a testament to the entire medicinal cannabis ecosystem, including our trusted suppliers, phenomenal doctors, pharmacists, nurses, and so many more who collaborate daily to reduce stigma, improve patient access, and provide the best care possible to Australian patients."
Varley said that in a rapidly evolving industry it was essential to "push the boundaries of innovation to support the needs of Australian patients" and to guarantee access to high-quality, effective treatments across the country.
"This recognition not only helps break down the barriers surrounding this treatment alternative, but also underscores its importance as a critical part of the future of healthcare," she added.
CEO Magazine's Executive of the Year awards ceremony is scheduled to take place at The Star in Sydney on November 14.
